Ann: Quarterly update and Appendix 4C, page-20

Yes, though wonder why sometimes as their communication with shareholders is nothing short of abysmal.
This months quarterly will be along the lines of - $4million down the gurgler. Covid numbers are down. No new contracts, and FDA submission still not in but should be by end of next year sometime. Revenue down because its been a mild winter in Australia.
Investor presentation will come out in two weeks telling us what we already know, and theyll do the same repetetive interview on ********* telling us how rosy everything is.